您的位置: 首页 > 农业专利 > 详情页

A small molecule inhibitor of MyD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure
专利权人:
Government of the United States, as represented by the Secretary of the Army, on behalf of Army Medical Research Institute of Infectious Diseases;The Scripps Research Institute
发明人:
GLASS, Pamela J,SAIKH, Kamal U,REBEK, Jr., Julius M
申请号:
AU2015272048
公开号:
AU2015272048B2
申请日:
2015.06.05
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
A synthetic molecule 4210 and a therapeutic use of a synthetic small molecule 4210 for treating viral infections, especially encephalitic alphavirus infections. The compound 4210 showed antiviral efficacy by up regulation type 1 interferon (IFN) specifically IFN-β. The compound 4210 was designed and synthesized by a structure- based approach targeting intracellular adaptor protein, myeloid differentiation primary response protein 88 (MyD88). Besides having an antiviral effect, the compound 4210 also demonstrated therapeutic efficacy for treating inflammatory syndrome associated with Gram positive bacterial infections such as exposure to staphylococcal enterotoxin B (SEB) induced toxic shock syndrome (TSS) in mice and can potentially be used in clinical set up for treating sepsis and septic shock. In addition, the application of molecule 4210 can treat sepsis and septic shock triggered by exposure to other biological agents such as
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充